Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: A retrospective registry study from the European group for blood and marrow transplantation (EBMT)

Bone Marrow Transplantation

Volumn 27, Issue 5, 2001, Pages 511-515

  Bjorkstrand B ^a   Svensson, H ^a   Goldschmidt, H ^b   Ljungman, P ^a   Apperley, J ^c   Mandelli, F ^d   Marcus, R ^e   Boogaerts, M ^f   Alegre, A ^g   Remes, K ^h   Cornelissen, J J ⁱ   Blade J ^j   Lenhoff, S ^k   Iriondo, A ^l   Carlson, K ^m   Volin, L ⁿ   Littlewood, T ^o   Goldstone, A H ^p   San Miguel, J ^q   Schattenberg, A ^r   Gahrton, G ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^h TURKU UNIVERSITY HOSPITAL   (Finland)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j HOSPITAL CLÍNIC   (Spain)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

^l HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^m UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁿ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^o JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^p UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^q HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^r RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Alpha interferon; Autologous stem cell transplantation; Multiple myeloma

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CANCER GROWTH; CANCER MORTALITY; CANCER REGISTRY; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; EUROPE; EVALUATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SIDE EFFECT; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 17744364469     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702826     Document Type: Article

References (23)

1. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma - A retrospective case-matched study from the European Group for Blood and Marrow Transplantation
2. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
3. Interferon therapy in myelomatosis
4. Post-remission treatment in acute myeloid leukemia: Chemotherapy or autologous or allogeneic bone marrow transplantation
5. A randomized clinical trial comparing melphalan/prednisolone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: A Cancer and Leukemia Group B study
6. Natural interferon-α in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: A randomized study from the Myeloma Group of Central Sweden
7. Combination chemotherapy, glucocorticoids and interferon alfa in the treatment of multiple myeloma: A Southwest Oncology Group study
8. Interferon-alpha for induction and maintenance in multiple myeloma: Results of two multicentre randomized trials and summary of other studies
9. Interferon-α2b added to melphalan-prednisolone for initial and maintenance therapy in multiple myeloma: A randomized, controlled trial
10. Maintenance treatment with interferon alpha-2b in multiple myeloma: A prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology)
11. Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma
12. Intensive combined therapy for previously untreated aggressive myeloma
13. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French registry on autologous transplantation in multiple myeloma
14. Autologous peripheral blood stem cell transplantation for multiple myeloma: A report of 259 cases from the Spanish registry
15. A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: Long-term follow-up results
16. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy
17. Interferon α-2b (IFN) maintenance therapy prolongs progression free and overall survival in plasma cell myeloma (PCM)
18. Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: A randomized study
19. A comparison of polychemotherapy and melphalan prednisolone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma: A prospective trial of the German Myeloma Treatment Group
20. MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma. MRC Working Party on Leukaemia in Adults
21. Patient preferences for interferon alfa in multiple myeloma
22. Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma